Abstract A024: Substance use disorder–associated cancer mortality in the United States, 1999–2020: Widening geographic and rural–urban disparities
Abstract
Substance use disorders (SUDs) and cancer share behavioral, commercial, environmental, and structural drivers, including tobacco, alcohol, drug exposure, psychosocial stress, deprivation, and unequal access to prevention, diagnosis, harm reduction, and oncology care. National mortality patterns for cancer deaths in which SUD is documented as a contributing cause remain poorly characterized. We analyzed U.S. CDC WONDER Multiple Cause of Death data from 1999-2020 for deaths with neoplasms as the underlying cause and SUD as a contributing cause. Counts, crude rates, and age-adjusted rates (AARs) were examined overall and by census region, state, urbanization, 10-year age group, race, Hispanic origin, sex, place of death, and neoplasm type. Log-linear regression estimated APC/AAPC; piecewise regression identified periods of increase or decline. From 1999-2020, 1,605,070 deaths were identified. Deaths increased from 8,673 to 103,908 (+1,098.1%), while the AAR rose from 3.2 to 24.2 per 100,000 (+656.3%; AAPC, 9.4%/year; 95% CI, 5.8-13.1; P<0.001). Segmented analysis showed non-significant change in 1999-2002 (APC, 7.2%; P=0.33), sharp increase in 2003-2006 (24.3%; P=0.038), continued increase in 2007-2012 (3.6%; P=0.004), and AAR decline in 2013-2020 (-1.7%; P=0.001), despite high death counts. In 2020, the Midwest had the highest regional AAR (34.7), followed by the South (24.7), Northeast (22.7), and West (14.7). Nonmetro rates were highest: NonCore 37.8 and micropolitan 36.2, versus large central metro 15.5. Highest state AARs were in Maine (50.7), Kentucky (48.9), Vermont (45.5), Tennessee (41.9), and South Dakota (41.0); fastest long-term increases occurred in Kentucky (AAPC, 18.6%), Indiana (18.2%), Arkansas (18.1%), Illinois (17.6%), and Missouri (17.4%). By race, 2020 AARs were highest among White persons (25.8), followed by Black persons (21.5), American Indian/Alaska Native persons (17.8), and Asian/Pacific Islander persons (6.0). Non-Hispanic persons had a higher AAR than Hispanic persons (26.1 vs 7.8). Males had nearly double the female AAR (32.6 vs 17.5). Age-specific rates were highest at 75-84 years (171.0), 85+ years (155.9), and 65-74 years (110.5). Most 2020 deaths occurred at home (54,435; 52.4%), followed by inpatient facilities (22,079; 21.2%) and hospice (12,372; 11.9%). Lung/bronchus malignancy accounted for 1,074,617 deaths (67.0%); leading 2020 cancer types included lung/bronchus (59,707), unspecified site (4,245), esophagus (3,472), and pancreas (3,418). Cancer deaths with SUD as a contributing cause increased steeply and clustered by geography, rurality, sex, age, race/ethnicity, place of death, and cancer type. Reducing this burden requires more than individual behavior change: health systems and communities must build environments that make healthy choices easier through harm reduction, cancer screening, integrated addiction-oncology care, rural outreach, palliative support, and policies that reduce structural exposure to carcinogenic and addictive products. Lakshmi Chandana Velaga, FNU Bhuvan, Prithvi Raghavan, Digantkumar Patel, Haritej Reddy Avisina, Hardik Dineshbhai Desai. Substance use disorder–associated cancer mortality in the United States, 1999–2020: Widening geographic and rural–urban disparities [abstract]. In: Proceedings of the 19th AACR Conference on the Science of Cancer Health Disparities; 2026 Oct 18-21; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2026;35(10 Suppl):Abstract nr A024.